PMA P160045S036

Device
Oncomine Dx Target Test
Applicant
Life Technologies Corporation
PMA number
P160045
Supplement
S036
Product code
PQP
Decision date
2022-08-11
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Approval order statement
Approval to reduce the number of replicates assessed for quality control (QC) release testing.

Current openFDA PMA Record#

Device
Oncomine Dx Target Test
Applicant
Life Technologies Corporation
PMA number
P160045
Supplement
S036
Product code
PQP
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Decision date
2022-08-11
Decision code
APPR
Date received
2022-03-29
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Approval to reduce the number of replicates assessed for quality control (QC) release testing.